About the Company
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers (i.e. home health, hospice, skilled nursing facilities, life plan communities, senior living centers, and private duty). Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on RESMED INC
Resmed, Inc.: Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in th ...
ResMed Updates Dividend Exchange Rate for ASX CDI Holders
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) just unveiled an announcement. ResMed Inc has announced an ...
Here's How Much You'd Have If You Invested $1000 in ResMed a Decade Ago
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and ...
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (RMD) today announced results for its quarter ended September 30, 2024. First Quarter 2025 Highlights ...
ResMed share price is on watch for all-time highs
The ResMed share price is nearing record territory after strong FY 2025 results, upbeat guidance, and a $150m buyback plan.
ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run?
Shares of ResMed (RMD) have been strong performers lately, with the stock up 7.1% over the past month. The stock hit a new 52-week high of $260.49 in the previous session. ResMed has gained 48.9% ...
ResMed Inc. stock falls Thursday, underperforms market
Shares of ResMed Inc. RMD slid 1.03% to $284.72 Thursday, on what proved to be an all-around mixed trading session for the ...
Ex-Dividend Reminder: Ford Motor, FirstEnergy and ResMed
Looking at the universe of stocks we cover at Dividend Channel, on 11/7/24, Ford Motor Co. (Symbol: F), FirstEnergy Corp (Symbol: FE), and ResMed Inc. (Symbol: RMD) will all trade ex-dividend for ...
ResMed is an ASX share market success story that deserves your attention
Here's why ResMed Inc. (ASX: RMD) is an ASX share market success that could be destined for even bigger things in the ...
ResMed Inc (RMD) Q4 2025 Earnings Call Highlights: Strong Revenue ...
ResMed Inc (RMD) reports a robust quarter with a 10% revenue increase, strategic acquisitions, and enhanced shareholder returns.
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb
Resmed Inc. ’s RMD adjusted earnings per share (EPS) in the fourth quarter of fiscal 2025 were $2.55, up 22.6% year over year. The metric beat the Zacks Consensus Estimate by 3.66%.
Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year ...
Revenue increased by 10% to $1.3 billion; up 9% on a constant currency basis Gross margin improved 230 bps to 60.8%; non-GAAP gross margin improved 230 bps to 61.4% Income from operations ...
Similar Companies
Loading the latest forecasts...